Dexcom Inc (NASDAQ: DXCM) is -35.50% lower on its value in year-to-date trading and has touched a low of $62.34 and a high of $142.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DXCM stock was last observed hovering at around $75.82 in the last trading session, with the day’s gains setting it 4.22%.
Currently trading at $80.04, the stock is 2.46% and 7.64% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.49 million and changing 5.57% at the moment leaves the stock -17.92% off its SMA200. DXCM registered -31.38% loss for a year compared to 6-month loss of -27.61%. The firm has a 50-day simple moving average (SMA 50) of $74.3564 and a 200-day simple moving average (SMA200) of $97.5193.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 6.38% gain in the last 1 month and extending the period to 3 months gives it a 14.84%, and is 3.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.94% over the week and 3.32% over the month.
Dexcom Inc (DXCM) has around 9600 employees, a market worth around $33.00B and $3.95B in sales. Current P/E ratio is 47.98 and Fwd P/E is 39.25. Profit margin for the company is 17.22%. Distance from 52-week low is 28.39% and -43.63% from its 52-week high. The company has generated returns on investments over the last 12 months (14.97%).
with sales reaching $1.1B over the same period.The EPS is expected to grow by 12.21% this year, but quarterly earnings will post 10.86% year-over-year. Quarterly sales are estimated to grow 5.91% in year-over-year returns.
Dexcom Inc (DXCM) Top Institutional Holders
1364.0 institutions hold shares in Dexcom Inc (DXCM), with institutional investors hold 97.40% of the company’s shares. The shares outstanding are 390.60M, and float is at 385.65M with Short Float at 2.18%. Institutions hold 97.09% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 46.51 million shares valued at $5.27 billion. The investor’s holdings represent 11.9203% of the DXCM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 34.52 million shares valued at $3.91 billion to account for 8.8466 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.31 million shares representing 4.1796% and valued at over $1.85 billion, while BAILLIE GIFFORD & CO holds 3.9277 of the shares totaling 15.33 million with a market value of $1.74 billion.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by Stern Sadie, the company’s EVP, Chief HR Officer. SEC filings show that Stern Sadie sold 424 shares of the company’s common stock on Dec 16 ’24 at a price of $76.87 per share for a total of $32593.0. Following the sale, the insider now owns 70768.0 shares.
Dexcom Inc disclosed in a document filed with the SEC on Dec 16 ’24 that Sylvain Jereme M (EVP, Chief Financal Officer) sold a total of 744 shares of the company’s common stock. The trade occurred on Dec 16 ’24 and was made at $76.87 per share for $57191.0. Following the transaction, the insider now directly holds 80030.0 shares of the DXCM stock.
Still, SEC filings show that on Dec 16 ’24, Leach Jacob Steven (EVP, Chief Operating Officer) disposed off 744 shares at an average price of $76.87 for $57191.0. The insider now directly holds 264,171 shares of Dexcom Inc (DXCM).
